Mixtard 40iu Penfil

Mixtard 40 IU Penfill combines 30% soluble and 70% isophane human insulin to provide both rapid and intermediate-acting insulin coverage. It is ideal for adults and children managing type 1 or type 2 diabetes.

Available Models/Sizes/Variations

• Penfill cartridge: 3 mL containing 40 IU/mL
• 30% soluble + 70% isophane human insulin

Main Intended Uses (with localized benefits)

• Post-meal and basal blood glucose control in type 1 diabetes
• Supplementary insulin for type 2 diabetes needing mixed insulin
• Supports diabetes management in Tanzania in both home and clinic settings

Operating Instructions

1. Check that insulin solution is uniformly cloudy before injection.
2. Use with compatible insulin pen devices only.
3. Administer subcutaneously, rotating injection sites to prevent lipodystrophy.
4. Individualize dose based on blood glucose monitoring and physician guidance.
5. Discard cartridge 4 weeks after first use.

Potential Risks / Adverse Events

• Hypoglycemia (low blood sugar)
• Injection site reactions (redness, swelling)
• Weight gain, rare allergic reactions

Interactions / Compatibility

• May interact with oral antidiabetic drugs, corticosteroids, beta-blockers, ACE inhibitors, or other glucose-altering medications.

Warnings / Precautions (with localized warnings)

• Do not mix with other insulin types unless prescribed.
• Store in refrigerator at 2–8°C; do not freeze.
• Monitor blood glucose regularly to prevent hypoglycemia.

Quick Device Facts Table

Item	Detail
Device Type	Mixed human insulin (30/70)
Intended Use	Basal and mealtime blood glucose control
Operating Environment	Home or clinic; subcutaneous injection via pen
Sterilization Method	Single-use pen cartridges
Potential Risks	Hypoglycemia, injection site reactions
Warnings	Store 2–8°C; discard after 4 weeks

Mechanism of Operation